Reshape Lifesciences Inc
(RSLS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 3,221 | 3,206 | 3,602 | 1,702 | 2,789 |
| Cost of Goods | 937 | 1,566 | 1,321 | 865 | 1,285 |
| Gross Profit | 2,284 | 1,640 | 2,281 | 837 | 1,504 |
| Operating Expenses | 5,478 | 5,412 | 4,774 | 4,700 | 5,870 |
| Operating Income | -2,257 | -3,206 | -2,172 | -2,998 | -4,081 |
| Interest Expense | 599 | 417 | 739 | 789 | 104 |
| Other Income | -1,993 | -4,987 | -2,307 | 133 | -144 |
| Pre-tax Income | -4,849 | -8,610 | -5,218 | -3,654 | -4,329 |
| Income Tax | 25 | -74 | -39 | -50 | -18 |
| Net Income Continuous | -4,874 | -8,536 | -5,179 | -3,604 | -4,311 |
| Net Income | $-4,874 | $-8,536 | $-5,179 | $-3,604 | $-4,311 |
| EPS Basic Total Ops | -0.70 | -1.23 | -0.74 | -0.52 | -0.63 |
| EPS Basic Continuous Ops | -0.70 | -1.23 | -0.74 | -0.52 | -0.63 |
| EPS Diluted Total Ops | -0.70 | -1.23 | -0.74 | -0.52 | -0.63 |
| EPS Diluted Continuous Ops | -0.70 | -1.23 | -0.74 | -0.52 | -0.63 |
| EPS Diluted Before Non-Recurring Items | -0.70 | -1.23 | -0.74 | -0.52 | -0.63 |
| EBITDA(a) | $-1,378 | $-2,491 | $-1,117 | $-1,872 | $-3,613 |